2 years ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#4935 out of 4937 analysts
Average Return
-13.32%
Win Rate
34%167 out of 494
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | +342.54% | $1.34 | $5.93 | 2025-04-14 - 2025-07-11 | Buy |
Immunomedics IncIMMU | +342.36% | $18.91 | $83.65 | 2020-04-07 - 2020-09-14 | Buy |
Adc Therapeutics SaADCT | +287.50% | $0.80 | $3.10 | 2023-09-19 - 2024-09-18 | Buy |
Turning Point Therapeutics IncTPTX | +208.74% | $35.13 | $108.46 | 2020-03-17 - 2021-03-17 | Buy |
Revolution Medicines IncRVMD | +201.93% | $19.65 | $59.33 | 2023-11-13 - 2024-11-12 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Karyopharm Therapeutics IncKPTI | 1 | Buy | $27.00 | +493.41% | Assumes | 2 days ago |
Cogent Biosciences IncCOGT | 11 | Buy | $22.00 | +100.36% | Maintains | 5 days ago |
Replimune Group IncREPL | 16 | Buy | $22.00 | +100.55% | Reiterates | 10 days ago |
Zymeworks IncZYME | 21 | Hold | $13.00 | -2.55% | Reiterates | 10 days ago |
Telix Pharmaceuticals LtdTLX | 1 | Buy | $23.00 | +44.02% | Initiates Coverage On | 10 days ago |
Enliven Therapeutics IncELVN | 5 | Buy | $48.00 | +113.81% | Maintains | 11 days ago |
Exelixis IncEXEL | 9 | Buy | $53.00 | +18.15% | Maintains | 13 days ago |
Biontech SeBNTX | 41 | Buy | $138.00 | +22.24% | Reiterates | 18 days ago |
IMMIX Biopharma IncIMMX | 8 | Buy | $7.00 | +164.15% | Reiterates | a month ago |
Y Mabs Therapeutics IncYMAB | 14 | Buy | $11.00 | +152.29% | Maintains | 2 months ago |
Bicara Therapeutics IncBCAX | 4 | Buy | $41.00 | +322.25% | Maintains | 2 months ago |
Tuhura Biosciences IncHURA | 3 | Buy | $12.00 | +421.74% | Reiterates | 2 months ago |
Arrivent Biopharma IncAVBP | 9 | Buy | $40.00 | +84.93% | Maintains | 2 months ago |
Revolution Medicines IncRVMD | 18 | Buy | $72.00 | +89.37% | Maintains | 2 months ago |
Oric Pharmaceuticals IncORIC | 24 | Buy | $22.00 | +98.20% | Maintains | 2 months ago |
Cardiff Oncology IncCRDF | 2 | Buy | $18.00 | +342.26% | Maintains | 2 months ago |
Prelude Therapeutics IncPRLD | 16 | Buy | $5.00 | +513.50% | Reiterates | 2 months ago |
Springworks Therapeutics IncSWTX | 29 | Hold | $47.00 | +0.02% | Downgrades | 2 months ago |
Caribou Biosciences IncCRBU | 14 | Buy | $3.00 | +84.05% | Maintains | 2 months ago |
Tango Therapeutics IncTNGX | 12 | Buy | $13.00 | +119.22% | Reiterates | 3 months ago |
Nurix Therapeutics IncNRIX | 15 | Buy | $36.00 | +189.39% | Reiterates | 3 months ago |
Elicio Therapeutics IncELTX | 7 | Buy | $10.00 | +23.76% | Reiterates | 3 months ago |
Adc Therapeutics SaADCT | 18 | Buy | $8.00 | +153.97% | Reiterates | 3 months ago |
Perspective Therapeutics IncCATX | 3 | Buy | $10.00 | +151.26% | Reiterates | 3 months ago |
Macrogenics IncMGNX | 18 | Hold | $2.00 | +24.22% | Maintains | 4 months ago |
Pmv Pharmaceuticals IncPMVP | 11 | Buy | $5.00 | +296.83% | Reiterates | 4 months ago |
Allogene Therapeutics IncALLO | 14 | Buy | $8.00 | +525.00% | Maintains | 4 months ago |
Black Diamond Therapeutics IncBDTX | 13 | Buy | $12.00 | +318.12% | Maintains | 4 months ago |
Onkure Therapeutics IncOKUR | 3 | Buy | $34.00 | +1,260.00% | Maintains | 4 months ago |
Nuvation Bio IncNUVB | 14 | Buy | $10.00 | +354.55% | Maintains | 4 months ago |
Repare Therapeutics IncRPTX | 18 | Buy | $5.00 | +233.33% | Maintains | 4 months ago |
Relay Therapeutics IncRLAY | 20 | Buy | $16.00 | +344.44% | Reiterates | 4 months ago |
Cargo Therapeutics IncCRGX | 3 | Buy | $33.00 | +618.95% | Reiterates | 8 months ago |
Igm Biosciences IncIGMS | 13 | Hold | $11.00 | +708.82% | Maintains | 10 months ago |
Kronos Bio IncKRON | 10 | Buy | $2.25 | +155.68% | Reiterates | a year ago |
Omega Therapeutics IncOMGAQ | 9 | Buy | $12.00 | +8,291.61% | Reiterates | a year ago |
Apollomics IncAPLM | 5 | Buy | $200.00 | N/A | Maintains | a year ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | N/A | Reiterates | a year ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | N/A | Reiterates | a year ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $20.00 | N/A | Maintains | a year ago |
Kineta IncKANT | 4 | Buy | $8.00 | N/A | Reiterates | a year ago |
Portage Biotech IncPRTG | 5 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Whitehawk Therapeutics IncWHWK | 9 | Buy | $36.00 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 6 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Gt Biopharma IncGTBP | 6 | Buy | $150.00 | N/A | Reiterates | 2 years ago |
Atara Biotherapeutics IncATRA | 8 | Buy | $700.00 | N/A | Maintains | 2 years ago |
Ikena Oncology IncIKNA | 4 | Buy | $22.00 | N/A | Reiterates | 2 years ago |
Fate Therapeutics IncFATE | 6 | Hold | $7.00 | N/A | Downgrades | 2 years ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | N/A | Maintains | 3 years ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 3 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 4 years ago |
Nucana PLCNCNA | 7 | Buy | $225.00 | N/A | Maintains | 4 years ago |
Molecular Partners AgMOLN | 1 | Buy | $25.00 | N/A | Assumes | 4 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 5 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.